Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy.

Gajewski TF. Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy. Pigment Cell Melanoma Res. 2010 Oct; 23(5):580-1.

View in: PubMed

collapse authors with profiles